AMACR
Alpha-methylacyl-CoA racemase
Also known as: AMACR_HUMAN, P504S, RACE
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9UHK6
- Gene
- AMACR
- Ensembl
- ENSG00000242110
- Chromosome
- 5
- Canonical length
- 382 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Vesicles,Peroxisomes,Plasma membrane,Cytosol
OverviewNCBI Gene
This gene encodes a racemase. The encoded enzyme interconverts pristanoyl-CoA and C27-bile acylCoAs between their (R)- and (S)-stereoisomers. The conversion to the (S)-stereoisomers is necessary for degradation of these substrates by peroxisomal beta-oxidation. Encoded proteins from this locus localize to both mitochondria and peroxisomes. Mutations in this gene may be associated with adult-onset sensorimotor neuropathy, pigmentary retinopathy, and adrenomyeloneuropathy due to defects in bile acid synthesis. Alternatively spliced transcript variants have been described. Read-through transcription also exists between this gene and the upstream neighboring C1QTNF3 (C1q and tumor necrosis factor related protein 3) gene. [provided by RefSeq, Mar 2011]
Canonical amino-acid sequenceUniProt
382 residues, UniProt reviewed canonical sequence.
>Q9UHK6|AMACR
1 MALQGISVVE LSGLAPGPFC AMVLADFGAR VVRVDRPGSR YDVSRLGRGK RSLVLDLKQP
61 RGAAVLRRLC KRSDVLLEPF RRGVMEKLQL GPEILQRENP RLIYARLSGF GQSGSFCRLA
121 GHDINYLALS GVLSKIGRSG ENPYAPLNLL ADFAGGGLMC ALGIIMALFD RTRTGKGQVI
181 DANMVEGTAY LSSFLWKTQK LSLWEAPRGQ NMLDGGAPFY TTYRTADGEF MAVGAIEPQF
241 YELLIKGLGL KSDELPNQMS MDDWPEMKKK FADVFAEKTK AEWCQIFDGT DACVTPVLTF
301 EEVVHHDHNK ERGSFITSEE QDVSPRPAPL LLNTPAIPSF KRDPFIGEHT EEILEEFGFS
361 REEIYQLNSD KIIESNKVKA SLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against AMACR can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 168 nTPM
Expression across tissuesHPA
Tissue
- liver: 168 nTPM
- kidney: 125 nTPM
- salivary gland: 56 nTPM
- rectum: 40 nTPM
- colon: 37 nTPM
- prostate: 36 nTPM
Single-cell type
- hepatocytes: 25 nCPM
- respiratory ionocytes: 15 nCPM
- other brain neurons: 15 nCPM
- bergmann glia: 14 nCPM
- microglia: 14 nCPM
- colonocytes: 12 nCPM
Immune cell
- non-classical monocyte: 14 nTPM
- neutrophil: 9 nTPM
- eosinophil: 8.8 nTPM
- myeloid DC: 8.6 nTPM
- NK-cell: 8.4 nTPM
- gdT-cell: 7.6 nTPM
Brain region
- hypothalamus: 12 nTPM
- pons: 9.8 nTPM
- white matter: 9.2 nTPM
- spinal cord: 8.9 nTPM
- cerebral cortex: 8.8 nTPM
- midbrain: 8.8 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about AMACR.
Disease | AllUniProt
Conditions AMACR is implicated in, by any mechanism.
- Alpha-methylacyl-CoA racemase deficiency (AMACRD) MIM:614307
- Congenital bile acid synthesis defect 4 (CBAS4) MIM:214950
Disease | GeneticClinVar
4 pathogenic / likely-pathogenic of 453 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Congenital bile acid synthesis defect 4
- Inborn genetic diseases
- Alpha-methylacyl-CoA racemase deficiency
- AMACR-related disorder
- Autosomal recessive AMACR-related disorders
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.75
- gnomAD pLI
- 0.03
- gnomAD missense Z
- 0.56
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- bile acid biosynthetic process
- bile acid metabolic process
- fatty acid beta-oxidation using acyl-CoA oxidase
Molecular functions
- signaling receptor binding
- alpha-methylacyl-CoA racemase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads AMACR as an antibody target. Whether an autoantibody or antibody against AMACR could matter depends on whether native AMACR is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
AMACR is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label AMACR as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...